Competitors of in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,354 Cr. | 308 | 390/128 | 63.6 | 20.5 | 0.22 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 62.6 Cr. | 84.4 | 94.9/26.6 | 24.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 35.9 Cr. | 24.5 | 24.5/8.74 | 46.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 86.7 Cr. | 115 | 155/87.0 | 13.0 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,416 Cr. | 1,013 | 1,335/645 | 29.3 | 207 | 2.22 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 390 Cr. | 17.2 | 29.0/13.2 | 22.6 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 9.01 Cr. | 18.6 | 28.5/15.0 | 180 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 352 Cr. | 750 | 1,054/650 | 19.9 | 278 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 59.3 Cr. | 19.8 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,130 Cr. | 384 | 440/145 | 138 | 98.6 | 0.33 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.52 Cr. | 31.0 | 43.8/23.6 | 130 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.6 Cr. | 7.88 | 19.4/7.17 | 43.6 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 216 Cr. | 270 | 270/110 | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 213 Cr. | 2.29 | 3.03/1.03 | 288 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 17.9 Cr. | 7.46 | 14.5/6.40 | 21.6 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 16.0 Cr. | 15.9 | 25.8/14.4 | 19.3 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 262 Cr. | 734 | 999/345 | 11.3 | 570 | 0.27 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.4 Cr. | 37.4 | 61.5/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 32.8 Cr. | 71.7 | 84.4/36.0 | 59.6 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 10.8 Cr. | 4.34 | 26.5/4.12 | 43.4 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 14.0 Cr. | 93.5 | 154/52.2 | 11.2 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.58 Cr. | 13.9 | 17.4/4.37 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 49.0 Cr. | 65.0 | 148/63.0 | 31.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.82 Cr. | 22.7 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 101 Cr. | 23.4 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 19.2 Cr. | 37.8 | 46.0/22.1 | 56.4 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 197 Cr. | 342 | 418/188 | 20.3 | 110 | 1.31 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 36.1 Cr. | 61.3 | 62.6/5.69 | 92.6 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 72,756 Cr. | 1,242 | 1,593/958 | 20.0 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 176 Cr. | 282 | 307/118 | 28.5 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,117 Cr. | 223 | 265/146 | 18.9 | 60.5 | 1.12 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 59.1 Cr. | 45.3 | 86.1/43.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,680 Cr. | 2,120 | 2,320/1,004 | 92.9 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 7.93 Cr. | 1.20 | 1.45/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 438 Cr. | 57.2 | 77.7/37.5 | 32.9 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.0 Cr. | 22.2 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 94.0 Cr. | 3.99 | 6.25/2.87 | 142 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 60,893 Cr. | 28,655 | 30,521/22,239 | 47.4 | 1,657 | 1.43 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,174 Cr. | 571 | 722/381 | 22.7 | 205 | 0.53 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 165 Cr. | 59.0 | 75.8/37.0 | 23.9 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,148 Cr. | 784 | 822/440 | 58.0 | 0.13 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 23,629 Cr. | 1,454 | 1,537/403 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 932 Cr. | 284 | 325/122 | 33.8 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 9.38 % | 233 % | 2.00 | |
| Venus Remedies Ltd | 418 Cr. | 313 | 430/280 | 18.9 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,064 Cr. | 719 | 950/401 | 101 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,040 Cr. | 1,443 | 1,923/1,232 | 31.5 | 735 | 0.69 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,16,318 Cr. | 3,437 | 3,591/2,223 | 66.8 | 222 | 0.81 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,473 Cr. | 269 | 317/181 | 46.7 | 44.8 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,919 Cr. | 20.4 | 27.9/11.0 | 60.4 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 30,170 Cr. | 1,185 | 1,360/585 | 124 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,938 Cr. | 135 | 169/78.1 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,34,004 Cr. | 1,809 | 1,960/1,239 | 38.7 | 288 | 0.75 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,994 Cr. | 687 | 886/303 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 1,960 Cr. | 232 | 398/118 | 33.4 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 364 Cr. | 1,204 | 1,750/495 | 17.9 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,952 Cr. | 813 | 960/313 | 138 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,435 Cr. | 177 | 241/91.8 | 208 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,191 Cr. | 6,162 | 7,600/4,606 | 33.7 | 298 | 2.71 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,655 Cr. | 2,210 | 2,977/1,306 | 42.0 | 229 | 0.72 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,075 Cr. | 5,467 | 5,850/4,637 | 40.0 | 324 | 1.10 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 208 Cr. | 59.0 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 21,364 Cr. | 4,670 | 6,453/3,950 | 34.9 | 820 | 0.75 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 257 Cr. | 209 | 348/190 | 14.1 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,745 Cr. | 448 | 491/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 9,082 Cr. | 1,791 | 1,850/692 | 76.3 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,822 Cr. | 13,891 | 18,100/5,021 | 67.5 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 937 Cr. | 41.8 | 56.5/26.2 | 87.4 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 25,379 Cr. | 1,417 | 1,639/788 | 13.1 | 399 | 0.67 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,378 Cr. | 79.9 | 101/38.6 | 33.3 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,817 Cr. | 305 | 359/126 | 39.9 | 50.3 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 182 Cr. | 115 | 145/85.2 | 19.3 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 534 Cr. | 150 | 177/97.9 | 169 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 98,114 Cr. | 2,151 | 2,312/1,265 | 37.4 | 343 | 0.37 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,627 Cr. | 812 | 980/498 | 16.8 | 319 | 0.22 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 30,150 Cr. | 559 | 593/359 | 128 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 886 Cr. | 854 | 961/372 | 25.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 210 Cr. | 97.4 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,047 Cr. | 217 | 370/198 | 19.8 | 103 | 1.38 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 521 Cr. | 324 | 470/298 | 37.0 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 16,911 Cr. | 1,062 | 1,310/526 | 59.4 | 373 | 0.47 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,421 Cr. | 1,892 | 2,030/1,474 | 48.1 | 207 | 0.65 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,746 Cr. | 658 | 820/270 | 65.2 | 74.4 | 0.76 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 40,149 Cr. | 1,582 | 1,709/1,052 | 64.4 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,469 Cr. | 420 | 538/331 | 24.6 | 283 | 1.19 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 157 Cr. | 29.0 | 32.6/14.3 | 2.86 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 633 Cr. | 107 | 186/86.2 | 6.20 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 3,134 Cr. | 340 | 417/286 | 141 | 118 | 0.44 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,666 Cr. | 378 | 465/260 | 63.5 | 97.6 | 0.32 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 2,018 Cr. | 2,372 | 3,379/1,293 | 86.0 | 355 | 0.25 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,335 Cr. | 432 | 504/278 | 51.0 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,365 Cr. | 592 | 725/382 | 29.5 | 141 | 0.25 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 43,504 Cr. | 1,542 | 1,831/767 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 38,556 Cr. | 2,276 | 3,088/1,746 | 48.1 | 98.7 | 1.41 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 29,199 Cr. | 1,772 | 2,221/1,586 | 26.5 | 557 | 1.13 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 8,002 Cr. | 492 | 659/390 | 25.3 | 141 | 1.02 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 18,790 Cr. | 1,380 | 1,594/809 | 54.1 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,12,116 Cr. | 1,344 | 1,421/1,104 | 21.0 | 369 | 0.60 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,325 Cr. | 276 | 308/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,18,885 Cr. | 1,472 | 1,702/1,232 | 25.8 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 17,570 Cr. | 2,311 | 2,540/1,221 | 35.6 | 334 | 0.22 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 420 Cr. | 160 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,698 Cr. | 161 | 180/92.2 | 19.2 | 96.0 | 0.31 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 96.4 Cr. | 59.2 | 92.0/53.4 | 182 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 40,334 Cr. | 336 | 396/244 | 28.0 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,980 Cr. | 2,060 | 2,326/1,060 | 48.3 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 192 Cr. | 121 | 158/89.0 | 25.2 | 43.2 | 0.99 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 193 Cr. | 81.4 | 113/73.2 | 250 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 16,220 Cr. | 6,488 | 8,140/4,050 | 126 | 272 | 0.37 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,166 Cr. | 749 | 863/556 | 45.6 | 103 | 0.61 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 244 Cr. | 116 | 145/69.9 | 11.8 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 64,894 Cr. | 5,428 | 6,440/4,407 | 29.9 | 961 | 0.74 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,740 Cr. | 1,055 | 1,304/746 | 32.6 | 249 | 1.04 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 752 Cr. | 1,318 | 1,754/960 | 11.0 | 724 | 0.87 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 35,805 Cr. | 2,866 | 3,486/1,951 | 40.9 | 294 | 1.26 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,041 Cr. | 361 | 571/334 | 27.6 | 120 | 1.41 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 3,937 Cr. | 428 | 635/420 | 31.5 | 126 | 0.23 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,016.52 Cr | 1,181.31 | 56.05 | 186.30 | 0.32% | 16.20% | 16.32% | 6.27 |
